From: Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma
Number of patients reporting event, n (%) | Placebo nDPI (n= 145) | Placebo DISKUS (n= 42) | FF 200 μg OD (n= 140) | FF 100 μg BD (n= 142) | FP 200 μg OD (n= 42) | FP 100 μg BD (n= 43) |
---|---|---|---|---|---|---|
Any on-treatment AE | 21 (14) | 5 (12) | 22 (16) | 26 (18) | 2 (5) | 3 (7) |
URTI | 2 (1) | 0 | 7 (5) | 7 (5) | 0 | 0 |
Sinusitis | 0 | 1 (2) | 1 (< 1) | 2 (1) | 0 | 0 |
Pharyngitis | 2 (1) | 0 | 1 (< 1) | 0 | 0 | 0 |
Cellulitis | 2 (1) | 0 | 0 | 0 | 0 | 0 |
Tooth infection | 0 | 0 | 2 (1) | 0 | 0 | 0 |
Cough | 0 | 0 | 0 | 2 (1) | 0 | 0 |
Headache | 2 (1) | 0 | 2 (1) | 0 | 0 | 0 |
Tension headache | 0 | 0 | 2 (1) | 0 | 0 | 0 |